Baker BROS. Advisors LP Invests $29.10 Million in Grail, Inc. (NASDAQ:GRAL)

Baker BROS. Advisors LP purchased a new stake in Grail, Inc. (NASDAQ:GRAL) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 1,630,125 shares of the company’s stock, valued at approximately $29,098,000. Baker BROS. Advisors LP owned approximately 4.85% of Grail at the end of the most recent reporting period.

Other institutional investors have also recently bought and sold shares of the company. FNY Investment Advisers LLC acquired a new stake in shares of Grail in the 4th quarter valued at $26,000. State of Tennessee Department of Treasury bought a new position in Grail during the 4th quarter worth approximately $28,000. Lindbrook Capital LLC acquired a new position in shares of Grail in the 4th quarter valued at $28,000. Sterling Capital Management LLC bought a new stake in shares of Grail in the 4th quarter valued at $29,000. Finally, Wellington Shields Capital Management LLC acquired a new stake in Grail during the 4th quarter worth $33,000.

Insider Transactions at Grail

In other Grail news, CFO Aaron Freidin sold 1,816 shares of the business’s stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $31.20, for a total transaction of $56,659.20. Following the sale, the chief financial officer now directly owns 335,170 shares of the company’s stock, valued at $10,457,304. The trade was a 0.54 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, President Joshua J. Ofman sold 2,109 shares of the firm’s stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $31.20, for a total value of $65,800.80. Following the completion of the transaction, the president now owns 559,673 shares of the company’s stock, valued at $17,461,797.60. The trade was a 0.38 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 11,550 shares of company stock valued at $360,436 over the last 90 days.

Grail Stock Up 10.1 %

Shares of NASDAQ GRAL opened at $35.78 on Friday. The company has a fifty day moving average price of $30.08 and a 200 day moving average price of $25.08. Grail, Inc. has a 1-year low of $12.33 and a 1-year high of $63.99.

Grail (NASDAQ:GRAL) last posted its quarterly earnings data on Thursday, February 20th. The company reported ($1.86) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($4.41) by $2.55. The firm had revenue of $38.25 million for the quarter, compared to the consensus estimate of $35.33 million. As a group, sell-side analysts forecast that Grail, Inc. will post -15.15 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of research analysts have issued reports on the company. Morgan Stanley boosted their target price on Grail from $16.00 to $20.00 and gave the company an “equal weight” rating in a research note on Tuesday, March 18th. Canaccord Genuity Group assumed coverage on Grail in a research report on Monday, April 21st. They issued a “buy” rating and a $32.00 price objective for the company.

About Grail

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.